Research Article| Volume 95, ISSUE 2, P163-166, April 2001

Tissue factor (TF) and tissue factor pathway inhibitor (TFPI) in amniotic fluid and blood plasma: implications for the mechanism of amniotic fluid embolism


      Tissue factor (TF) is known to be present in a high concentration in amniotic fluid. The main question of this study is whether tissue factor pathway inhibitor (TFPI), a natural inhibitor of TF, is present in amniotic fluid. The study group consisted of 28 women with normal pregnancy course, and at the first stage of termed labour. Fifteen non-pregnant women were the control group. TF and TFPI were studied by an immunoenzymatic method (ELISA). The level of TFPI in amniotic fluid was 38.7% of that in blood plasma (16.81±5.34 ng/ml versus 43.41±18.70 ng/ml, P<0.001), while the level of TF in amniotic fluid was 44.8 times higher than in blood plasma (9995.93±8533.11 pg/ml versus 252.66±28.84 pg/ml, P<0.001). Conclusions: (i) It was found, for the first time, that amniotic fluid contains TFPI (ii) It is reasonable to assume that the intrusion of amniotic fluid into the blood-stream may influence the plasmatic TFPI–TF equilibrium resulting in intravascular blood coagulation.


      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


        • Petersen L.C.
        • Valentin S.
        • Hedner U.
        Regulation of the extrinsic pathway system in health and disease: the role of factor VIIa and tissue factor pathway inhibitor.
        Thromb. Res. 1995; 79: 1-47
        • Clark S.L.
        • Hankins G.D.V.
        • Dudley D.A.
        • Dildy G.A.
        • Porter T.F.
        Amniotic fluid embolism: analysis of the national registry.
        Am. J. Obstet. Gynecol. 1995; 172: 1159-1169
      1. Bielawiec M, Radziwon P, Mazgajska K, Giedrojć J, Galar M. TF concentration and TFPI concentration and activity in healthy volunteers Haemostasis 1996;26(Suppl. 3):525 (abstract).

        • Phillips L.L.
        • Davidson E.C.
        Procoagulant properties of amniotic fluid.
        Am. J. Obstet. Gynecol. 1972; 113: 911-919
        • Lockwood Ch.J.
        • Bach R.
        • Guha A.
        • Zhou X.
        • Miller W.A.
        • Nemerson Y.
        Amniotic fluid contains tissue factor, a potent initiator of coagulation.
        Am. J. Obstet. Gynecol. 1991; 165: 1335-1341
        • Bombeli T.
        • Mueller M.
        • Haeberli A.
        Anticoagulant properties of the vascular endothelium.
        Thromb. Haemost. 1997; 77: 408-423
        • Warr T.A.
        • Warn-Cramer B.J.
        • Rao L.V.M.
        • Rapaport S.I.
        Human plasma extrinsic pathway inhibitor activity. I. Standardisation of assay and evolution of psychologic variables.
        Blood. 1989; 74: 201-206
        • Sandest P.M.
        • Hellgren M.
        • Uvebrandt M.
        • Bergström H.
        Extrinsic coagulation pathway inhibitor and heparin cofactor II during normal and hypertensive pregnancy.
        Thromb. Res. 1989; 55: 665-670
        • Novotny W.F.
        • Brown S.G.
        • Miletich J.P.
        • Rader D.J.
        • Broze G.J.
        Plasma antigen levels of the lipoprotein-associated coagulation inhibitor in patient samples.
        Blood. 1991; 78: 387-393
        • Huang Z.F.
        • Higuchi D.
        • Lasky N.
        • Broze G.J.
        Tissue factor pathway inhibitor gene disruption produces intrauterine lethality in mice.
        Blood. 1997; 90: 944-951
        • Chan J.C.Y.
        • Carmeliet P.
        • Moons L.
        • Rosen E.D.
        • Huang Z.F.
        • Broze G.J.
        • Collen D.
        • Castellino F.J.
        Factor VII deficiency rescues the intrauterine lethality in mice associated with a tissue factor pathway inhibitor deficit.
        J. Clin. Invest. 1999; 103: 475-482
      2. Shimata H, Shiotani M, Nakamura K, Ikeuchi M, Hoshino T, Komatsu T, Hatori N, Ihara Y, Sohma Y, Maeda Y, Matsuura Y, Kasakura S, Nakamura S, Kato H. The hemostatic-fibrinolytic profiles of human follicular fluid in the preovulary phase. Fibrinolysis and protolysis 1998;(suppl. 1):247 (abstract).